SCHEMBL16838136

SCHEMBL16838136

CNc1ccc(F)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.42
TDO2 P48775 1/20 0.38
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
LMNA P02545 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
KCNH2 Q12809 1/20 0.36
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
VCP P55072 1/20 0.34
ABCC9 O60706 1/20 0.34
ABCC8 Q09428 1/20 0.34
KCNJ11 Q14654 1/20 0.34
KCNJ8 Q15842 1/20 0.34
KIF11 P52732 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27783419 0.98 IDO1 (0.41) IDO1TDO2TSHRNPSR1LMNA
SCHEMBL15828792 0.82 IDO1 (0.42) IDO1TSHRKCNH2CA12CA1
Hydrochloric Acid SCHEMBL29142225 0.80 IDO1 (0.41) IDO1TSHRKCNH2CA12CA1
SCHEMBL29661835 0.78 CA12 (0.38) TSHRLMNACA12CA1CA2
SCHEMBL31099069 0.78 RAPGEF4 (0.50) IDO1TSHRLMNAKCNH2KIF11
SCHEMBL1421215 0.78 RAPGEF4 (0.50) IDO1TSHRLMNAKCNH2KIF11
SCHEMBL11742333 0.78 CA12 (0.38) TSHRLMNACA12CA1CA2
SCHEMBL11425451 0.77 IDO1 (0.39) IDO1TDO2TSHRNPSR1LMNA
SCHEMBL16966569 0.77 ABL1 (0.44) IDO1TDO2TSHRNPSR1LMNA
Hydrochloric Acid SCHEMBL2020526 0.76 IDO1 (0.38) IDO1TDO2TSHRNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3889156-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2021-10-06 EP disclosed
EP-3312160-A1 HEPATITIS B ANTIVIRAL AGENTS Novira Therapeutics Inc. (US) 2018-04-25 EP disclosed
EP-2794565-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2017-07-26 EP disclosed
US-9061008-B2 Hepatitis B antiviral agents NOVIRA THERAPEUTICS, INC. (US) 2015-06-23 US disclosed
CN-102036996-A Bridged heterocycles as HIV integrase inhibitors BRISTOL MYERS SQUIBB CO 2011-04-27 CN disclosed
CN-1989141-B Bicyclic heterocycles as HIV integrase inhibitors BRISTOL MYERS SQUIBB CO 2010-06-16 CN disclosed
CN-1989141-A Bicyclic heterocycles as HIV integrase inhibitors BRISTOL MYERS SQUIBB CO (US) 2007-06-27 CN disclosed